Drug application
IMIPENEM AND CILASTATIN (CILASTATIN SODIUM, IMIPENEM)
Drugs@FDA ANDA 207594 · HQ SPCLT PHARMA
Key facts
| Drug name | IMIPENEM AND CILASTATIN |
|---|---|
| Active ingredients | CILASTATIN SODIUM, IMIPENEM |
| Application type | ANDA |
| Application number | 207594 |
| Company | HQ SPCLT PHARMA |
| Dosage forms | POWDER, INTRAVENOUS |
| Strength | EQ 500MG BASE/VIAL;500MG/VIAL |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Dec 12, 2019 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.